Company: SINT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024040
Chunk: 24

Company: Sintx Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 24
---
 offer stronger margins, a more defensible competitive position,
and better long-term value for shareholders.

While this strategic realignment has led to a temporary minor decline in
reported revenue, we believe it is a necessary step in positioning the Company for sustainable growth. During this transitional period,
we continue to invest in the development and regulatory advancement of silicon nitride-based orthopedic and surgical implants, as evidenced
by our recently submitted 510(k) for osteotomy wedges used in foot and ankle fusion procedures. We believe that these products will serve
as key revenue drivers in the future.

Cost
of revenue and Gross profit

For
the three months ended June 30, 2025, cost of revenue decreased $0.1 million, or 58%, compared to the same period in 2024 primarily due
to the decrease in revenue mentioned above.

For
the six months ended June 30, 2025, cost of revenue decreased $0.1 million, or 24%, compared to the same period in 2024 primarily due
to the decrease in revenue mentioned above.

Research
and development expenses

For
the three months ended June 30, 2025, research and development expenses decreased $0.4 million, or 26%, compared to the same period in
2024, primarily due to a decrease in payroll related costs.

For
the six months ended June 30, 2025, research and development expenses decreased $1.3 million, or 36%, compared to the same period in
2024, primarily due to a decrease in payroll related costs, patent expenses, protypes, and outside consulting costs.

General
and administrative expenses

For
the three months ended June 30, 2025, general and administrative expenses increased $0.2 million, or 22%, compared to the same
period in 2024, primarily due to fees paid to departing members of the Board of Directors, higher
accounting expenses, partially offset by lower legal expenses.

For
the six months ended June 30, 2025, general and administrative expenses increased $0.3 million, or 13%, compared to the same period
in 2024, primarily due to fees paid to departing members of the Board of Directors, partially offset by
lower legal expenses.

20

Sales
and marketing expenses

For
the three months ended June 30, 2025, sales and marketing expenses decreased $0.1 million, or 51%, compared to the